The University of Southampton
University of Southampton Institutional Repository

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision
In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002, World J Biol Psychiatry 3:171), recommendations for the pharmacological treatment of anxiety disorder, obsessive-compulsive disorder (OCD) and post-traumatic stress disorder (PTSD) are presented. Since the publication of the first version of this guideline, a substantial number of new randomized controlled studies of anxiolytics have been published. In particular, more relapse prevention studies are now available that show sustained efficacy of anxiolytic drugs. The recommendations, developed by the World Federation of Societies of Biological Psychiatry (WFSBP) Task Force for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-traumatic Stress Disorders, a consensus panel of 30 international experts, are now based on 510 published randomized, placebo- or comparator-controlled clinical studies (RCTs) and 130 open studies and case reports. First-line treatments for these disorders are selective serotonin reuptake inhibitors (SSRIs), serotonin-noradrenaline reuptake inhibitors (SNRIs) and the calcium channel modulator pregabalin. Tricyclic antidepressants (TCAs) are equally effective for some disorders, but many are less well tolerated than the SSRIs/SNRIs. In treatment-resistant cases, benzodiazepines may be used when the patient does not have a history of substance abuse disorders. Potential treatment options for patients unresponsive to standard treatments are described in this overview. Although these guidelines focus on medications, non-pharmacological were also considered. Cognitive behavioural therapy (CBT) and other variants of behaviour therapy have been sufficiently investigated in controlled studies in patients with anxiety disorders, OCD, and PTSD to support them being recommended either alone or in combination with the above medicines
post-traumatic, humans, therapy, biological psychiatry, standards, obsessive-compulsive disorder, world health, stress disorders, epidemiology, anxiety disorders, drug therapy
1562-2975
248-312
Bandelow, B.
f90459a9-1f40-40bb-bd92-d4c1e4cbb9f4
Zohar, J.
911e71d9-2491-4399-ab8d-d188934c3771
Hollander, E.
9627cb95-5730-46be-ad5d-38c9109ee7d4
Kasper, S.
d5cfec73-0b6a-4955-a152-8ceef1dcaa1d
Moller, H. J.
982dc3b5-0c75-4320-848c-311acfbbbe09
Allgulander, C.
2f6fea08-32e8-4b1b-81e7-9268a46c7542
Yuso-Gutierrez, J.
412daa83-c18d-4483-8a89-cf96a4bd911e
Baldwin, D. S.
1beaa192-0ef1-4914-897a-3a49fc2ed15e
Buenvicius, R.
605e931c-d302-4a4e-91a6-45c70b6f036a
Cassano, G.
22a9aaec-332d-47e0-9a23-31f299225800
Fineberg, N.
69eec4fd-1950-42a1-ae61-cab44427ed9c
Gabriels, L.
d40f8e05-8a68-4d82-a80a-bd387164563e
Hindmarch, I.
81b2cec5-e172-470a-81be-d4d700ba0602
Kaiya, H.
1008c920-7bb0-4075-b7bc-f065761780b3
Klein, D. F.
d14456c2-229f-4dab-9827-6c2c05db1836
Lader, M.
24f6301f-080d-452e-be88-7f528a99f3b9
Lecrubier, Y.
b6d960c6-b0f2-47eb-8d27-23da809bb0d7
Lepine, J. P.
d930cf08-829e-4b44-8b7b-b17ec0267172
Liebowitz, M. R.
49c55165-6f79-44d6-848a-7629cfcad777
Lopez-Ibor, J. J.
21aecbac-5489-4d8a-a2dc-ef957f7bcadf
Marazziti, D.
b2f40931-84dd-442a-83cf-7cfe1b02e781
Miguel, E. C.
e4a34878-3c50-4287-8e42-cc86e4126896
Oh, K. S.
72e54c12-1e2b-4125-adfd-e35a29f2e48d
Preter, M.
df865c27-fc86-4673-bab9-7aad9f03a347
Rupprecht, R.
ed41ffc4-2d60-4f76-95c5-fdb08153080a
Sato, M.
24cec4c2-58d0-4176-b472-335d9328d70b
Starcevic, V.
7820170c-edf0-4a5d-bae1-f28c685249f2
Stein, D. J.
ea73ce90-6195-47fa-8583-237c128091b2
Van Ameringen, M.
b74af8da-204b-4107-89dd-4f5d00e57737
Vega, J.
cc58687d-1fd0-4748-8efc-c9d2c8ff8fe0
Bandelow, B.
f90459a9-1f40-40bb-bd92-d4c1e4cbb9f4
Zohar, J.
911e71d9-2491-4399-ab8d-d188934c3771
Hollander, E.
9627cb95-5730-46be-ad5d-38c9109ee7d4
Kasper, S.
d5cfec73-0b6a-4955-a152-8ceef1dcaa1d
Moller, H. J.
982dc3b5-0c75-4320-848c-311acfbbbe09
Allgulander, C.
2f6fea08-32e8-4b1b-81e7-9268a46c7542
Yuso-Gutierrez, J.
412daa83-c18d-4483-8a89-cf96a4bd911e
Baldwin, D. S.
1beaa192-0ef1-4914-897a-3a49fc2ed15e
Buenvicius, R.
605e931c-d302-4a4e-91a6-45c70b6f036a
Cassano, G.
22a9aaec-332d-47e0-9a23-31f299225800
Fineberg, N.
69eec4fd-1950-42a1-ae61-cab44427ed9c
Gabriels, L.
d40f8e05-8a68-4d82-a80a-bd387164563e
Hindmarch, I.
81b2cec5-e172-470a-81be-d4d700ba0602
Kaiya, H.
1008c920-7bb0-4075-b7bc-f065761780b3
Klein, D. F.
d14456c2-229f-4dab-9827-6c2c05db1836
Lader, M.
24f6301f-080d-452e-be88-7f528a99f3b9
Lecrubier, Y.
b6d960c6-b0f2-47eb-8d27-23da809bb0d7
Lepine, J. P.
d930cf08-829e-4b44-8b7b-b17ec0267172
Liebowitz, M. R.
49c55165-6f79-44d6-848a-7629cfcad777
Lopez-Ibor, J. J.
21aecbac-5489-4d8a-a2dc-ef957f7bcadf
Marazziti, D.
b2f40931-84dd-442a-83cf-7cfe1b02e781
Miguel, E. C.
e4a34878-3c50-4287-8e42-cc86e4126896
Oh, K. S.
72e54c12-1e2b-4125-adfd-e35a29f2e48d
Preter, M.
df865c27-fc86-4673-bab9-7aad9f03a347
Rupprecht, R.
ed41ffc4-2d60-4f76-95c5-fdb08153080a
Sato, M.
24cec4c2-58d0-4176-b472-335d9328d70b
Starcevic, V.
7820170c-edf0-4a5d-bae1-f28c685249f2
Stein, D. J.
ea73ce90-6195-47fa-8583-237c128091b2
Van Ameringen, M.
b74af8da-204b-4107-89dd-4f5d00e57737
Vega, J.
cc58687d-1fd0-4748-8efc-c9d2c8ff8fe0

Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Moller, H. J., Allgulander, C., Yuso-Gutierrez, J., Baldwin, D. S., Buenvicius, R., Cassano, G., Fineberg, N., Gabriels, L., Hindmarch, I., Kaiya, H., Klein, D. F., Lader, M., Lecrubier, Y., Lepine, J. P., Liebowitz, M. R., Lopez-Ibor, J. J., Marazziti, D., Miguel, E. C., Oh, K. S., Preter, M., Rupprecht, R., Sato, M., Starcevic, V., Stein, D. J., Van Ameringen, M. and Vega, J. (2008) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. The World Journal of Biological Psychiatry, 9 (4), 248-312. (doi:10.1080/15622970802465807).

Record type: Article

Abstract

In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002, World J Biol Psychiatry 3:171), recommendations for the pharmacological treatment of anxiety disorder, obsessive-compulsive disorder (OCD) and post-traumatic stress disorder (PTSD) are presented. Since the publication of the first version of this guideline, a substantial number of new randomized controlled studies of anxiolytics have been published. In particular, more relapse prevention studies are now available that show sustained efficacy of anxiolytic drugs. The recommendations, developed by the World Federation of Societies of Biological Psychiatry (WFSBP) Task Force for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-traumatic Stress Disorders, a consensus panel of 30 international experts, are now based on 510 published randomized, placebo- or comparator-controlled clinical studies (RCTs) and 130 open studies and case reports. First-line treatments for these disorders are selective serotonin reuptake inhibitors (SSRIs), serotonin-noradrenaline reuptake inhibitors (SNRIs) and the calcium channel modulator pregabalin. Tricyclic antidepressants (TCAs) are equally effective for some disorders, but many are less well tolerated than the SSRIs/SNRIs. In treatment-resistant cases, benzodiazepines may be used when the patient does not have a history of substance abuse disorders. Potential treatment options for patients unresponsive to standard treatments are described in this overview. Although these guidelines focus on medications, non-pharmacological were also considered. Cognitive behavioural therapy (CBT) and other variants of behaviour therapy have been sufficiently investigated in controlled studies in patients with anxiety disorders, OCD, and PTSD to support them being recommended either alone or in combination with the above medicines

This record has no associated files available for download.

More information

Published date: 2008
Keywords: post-traumatic, humans, therapy, biological psychiatry, standards, obsessive-compulsive disorder, world health, stress disorders, epidemiology, anxiety disorders, drug therapy

Identifiers

Local EPrints ID: 70085
URI: http://eprints.soton.ac.uk/id/eprint/70085
ISSN: 1562-2975
PURE UUID: da736da0-c54d-4e39-a7e2-2cbd51e17e28
ORCID for D. S. Baldwin: ORCID iD orcid.org/0000-0003-3343-0907

Catalogue record

Date deposited: 21 Jan 2010
Last modified: 14 Mar 2024 02:38

Export record

Altmetrics

Contributors

Author: B. Bandelow
Author: J. Zohar
Author: E. Hollander
Author: S. Kasper
Author: H. J. Moller
Author: C. Allgulander
Author: J. Yuso-Gutierrez
Author: D. S. Baldwin ORCID iD
Author: R. Buenvicius
Author: G. Cassano
Author: N. Fineberg
Author: L. Gabriels
Author: I. Hindmarch
Author: H. Kaiya
Author: D. F. Klein
Author: M. Lader
Author: Y. Lecrubier
Author: J. P. Lepine
Author: M. R. Liebowitz
Author: J. J. Lopez-Ibor
Author: D. Marazziti
Author: E. C. Miguel
Author: K. S. Oh
Author: M. Preter
Author: R. Rupprecht
Author: M. Sato
Author: V. Starcevic
Author: D. J. Stein
Author: M. Van Ameringen
Author: J. Vega

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×